APG Asset Management US Inc. Takes $2.55 Million Position in Stryker Co. (NYSE:SYK)

APG Asset Management US Inc. purchased a new position in shares of Stryker Co. (NYSE:SYK - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 7,087 shares of the medical technology company's stock, valued at approximately $2,552,000.

Other institutional investors have also recently bought and sold shares of the company. Kohmann Bosshard Financial Services LLC purchased a new position in Stryker during the 4th quarter worth $25,000. Rakuten Securities Inc. grew its holdings in Stryker by 618.2% during the fourth quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock valued at $28,000 after purchasing an additional 68 shares during the period. Centricity Wealth Management LLC purchased a new position in shares of Stryker during the 4th quarter valued at $30,000. BankPlus Trust Department purchased a new stake in Stryker in the 4th quarter worth about $33,000. Finally, Activest Wealth Management purchased a new position in Stryker in the 4th quarter valued at approximately $36,000. Institutional investors and hedge funds own 77.09% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on SYK. JMP Securities reissued a "market perform" rating on shares of Stryker in a report on Tuesday, February 18th. Needham & Company LLC restated a "buy" rating and issued a $442.00 target price on shares of Stryker in a research report on Friday, March 21st. Wells Fargo & Company lifted their price objective on Stryker from $427.00 to $435.00 and gave the stock an "overweight" rating in a report on Wednesday, January 29th. Citigroup restated a "buy" rating and issued a $450.00 target price on shares of Stryker in a report on Wednesday, February 26th. Finally, Stifel Nicolaus lifted their price target on shares of Stryker from $400.00 to $440.00 and gave the company a "buy" rating in a report on Wednesday, January 29th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $423.05.

Insider Buying and Selling at Stryker

In other Stryker news, Director Allan C. Golston sold 2,458 shares of the stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total value of $941,586.06. Following the completion of the transaction, the director now owns 14,895 shares in the company, valued at approximately $5,705,827.65. This represents a 14.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Ronda E. Stryker sold 201,392 shares of Stryker stock in a transaction on Friday, January 31st. The stock was sold at an average price of $392.24, for a total value of $78,993,998.08. Following the transaction, the director now directly owns 3,642,075 shares of the company's stock, valued at approximately $1,428,567,498. This represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by corporate insiders.

Stryker Stock Up 0.4 %

SYK traded up $1.43 during trading hours on Monday, hitting $351.71. 449,529 shares of the company's stock were exchanged, compared to its average volume of 1,355,922. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 0.59. Stryker Co. has a 12-month low of $314.93 and a 12-month high of $406.19. The firm has a market cap of $134.24 billion, a P/E ratio of 45.32, a price-to-earnings-growth ratio of 2.93 and a beta of 0.93. The firm has a 50 day moving average of $375.54 and a 200 day moving average of $373.63.

Stryker (NYSE:SYK - Get Free Report) last issued its earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter last year, the firm posted $3.46 EPS. Analysts predict that Stryker Co. will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Investors of record on Monday, March 31st will be issued a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 0.96%. The ex-dividend date of this dividend is Monday, March 31st. Stryker's dividend payout ratio is presently 43.30%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.